Literature DB >> 18063050

Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.

Travis J Hollmann1, Stacey L Mueller-Ortiz, Michael C Braun, Rick A Wetsel.   

Abstract

The host response to intravascular, Gram-negative bacteria includes profound immunologic, hematologic and physiologic changes. Numerous host defense mechanisms are activated by Gram-negative bacteria, including the complement system. Activation of the complement system leads to cleavage of C5 with subsequent generation of the C5a anaphylatoxin peptide. C5a mediates potent, proinflammatory activities by binding to the C5a receptor (C5aR, CD88). In this study, we report the targeted disruption of the murine C5aR gene (C5aR-/- mice) and define the role of the C5aR in a model of Gram-negative bacteremia. Following an intravenous infusion of heat-killed Escherichia coli, the C5aR-/- mice were completely protected from the mortality suffered by their wild-type littermates (P<0.001). The C5aR-/- mice were also significantly (P=0.008) more resistant to mortality following an intravenous infusion of purified E. coli endotoxin compared to the wild-type littermates. In addition, the C5aR-/- mice were resistant to the thrombocytopenia and hemoconcentration observed in wild-type animals. Lethality in the wild-type mice was reversed by pre-treatment with either the histamine antagonist diphenhydramine or triprolidine. The wild-type littermates were also rescued following pre-treatment with the basophil and mast cell-stabilizing agent - cromolyn sodium. Collectively, these data demonstrate that not only is the absence of the C5aR protective in E. coli bacteremia, but that C5aR-dependent histamine release plays a major role in shock induced by Gram-negative septicemia. Moreover, they provide additional in vivo evidence that C3a and C5a have divergent biological functions in Gram-negative bacteremia and shock.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063050      PMCID: PMC4294580          DOI: 10.1016/j.molimm.2007.10.037

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  41 in total

1.  Chronological changes in the complement system in sepsis.

Authors:  H Nakae; S Endo; K Inada; M Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Authors:  S Stöve; T Welte; T O Wagner; A Kola; A Klos; W Bautsch; J Köhl
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

3.  Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells.

Authors:  T Takabayashi; E Vannier; J F Burke; R G Tompkins; J A Gelfand; B D Clark
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

4.  Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death.

Authors:  C Mohan; Y Yu; L Morel; P Yang; E K Wakeland
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.

Authors:  M K Pangburn; D C Morrison; R D Schreiber; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

Review 6.  Anaphylatoxins: possible roles in disease.

Authors:  W Vogt
Journal:  Complement       Date:  1986

7.  Circulating complement proteins in multiple trauma patients--correlation with injury severity, development of sepsis, and outcome.

Authors:  F Hecke; U Schmidt; A Kola; W Bautsch; A Klos; J Köhl
Journal:  Crit Care Med       Date:  1997-12       Impact factor: 7.598

8.  Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice.

Authors:  S L Ewart; D Kuperman; E Schadt; C Tankersley; A Grupe; D M Shubitowski; G Peltz; M Wills-Karp
Journal:  Am J Respir Cell Mol Biol       Date:  2000-10       Impact factor: 6.914

9.  Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3.

Authors:  B A Hug; R L Wesselschmidt; S Fiering; M A Bender; E Epner; M Groudine; T J Ley
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.

Authors:  P Li; H Allen; S Banerjee; S Franklin; L Herzog; C Johnston; J McDowell; M Paskind; L Rodman; J Salfeld
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

View more
  29 in total

1.  Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.

Authors:  Markus Bosmann; J Vidya Sarma; Gelareh Atefi; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2011-12-27       Impact factor: 5.191

Review 2.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

3.  The Complement Anaphylatoxins C5a and C3a Suppress IFN-β Production in Response to Listeria monocytogenes by Inhibition of the Cyclic Dinucleotide-Activated Cytosolic Surveillance Pathway.

Authors:  Stacey L Mueller-Ortiz; Daniel G Calame; Nancy Shenoi; Yi-Dong Li; Rick A Wetsel
Journal:  J Immunol       Date:  2017-03-08       Impact factor: 5.422

4.  Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.

Authors:  Z Shao; T Nishimura; L L K Leung; J Morser
Journal:  J Thromb Haemost       Date:  2015-05-10       Impact factor: 5.824

5.  C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.

Authors:  Bangqing Yuan; Fenlan Fu; Shaokuan Huang; Chuangan Lin; Guang Yang; Kunlong Ma; Hui Shi; Zhao Yang
Journal:  Mol Neurobiol       Date:  2016-10-05       Impact factor: 5.590

6.  Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2.

Authors:  Faith H Brennan; Trisha Jogia; Ellen R Gillespie; Linda V Blomster; Xaria X Li; Bianca Nowlan; Gail M Williams; Esther Jacobson; Geoff W Osborne; Frederic A Meunier; Stephen M Taylor; Kate E Campbell; Kelli Pa MacDonald; Jean-Pierre Levesque; Trent M Woodruff; Marc J Ruitenberg
Journal:  JCI Insight       Date:  2019-05-02

7.  The distinct function of Tep2 and Tep6 in the immune defense of Drosophila melanogaster against the pathogen Photorhabdus.

Authors:  Upasana Shokal; Hannah Kopydlowski; Ioannis Eleftherianos
Journal:  Virulence       Date:  2017-06-02       Impact factor: 5.882

8.  The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-10-08       Impact factor: 5.422

9.  Effects of Well-Controlled HIV Infection on Complement Activation and Function.

Authors:  Alexandria E-B Rossheim; Tina D Cunningham; Pamela S Hair; Tushar Shah; Kenji M Cunnion; Stephanie B Troy
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

10.  Complement activation in pediatric patients with recurrent acute otitis media.

Authors:  Yujuan He; Melissa A Scholes; Gregory J Wiet; Qian Li; Caitlin Clancy; Hua Hua Tong
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-03-26       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.